The efficacy of omega-3 fatty acids (O3FAs) as a complementary in colorectal cancer patients: A systematic review and meta-analysis
Clinical Nutrition ESPEN · 2024
DOI: 10.1016/j.clnesp.2024.04.002 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Clinical Nutrition ESPEN, 2024. Verfasst von Agung Ary Wibowo und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Digestive Division, Faculty of Medicine, Lambung Mangkurat University, Banjarmasin, Indonesia. Electronic address: agung.wibow…. Hauptthemen laut MEDLINE: Fatty Acids, Omega-3, Colorectal Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Onkologische Pflege
Abstract (Originalsprache)
BACKGROUND & AIMS: Colorectal cancer (CRC) is the third most common malignancy in developed countries. Therefore, omega-3 fatty acids (O3FAs) have been suggested as a beneficial complementary treatment due to their ability to regulate inflammatory responses and improve nutrition levels.This study aimed to evaluate the effects of O3FAs as a complementary treatment for inflammation, nutrition levels, post-operative infectious complications, and enhancement of recovery in CRC patients. METHODS: The literature search was carried out through three databases. The outcomes of interest were assessed by measuring pro-inflammatory cytokines (IL-1β, IL-6, and TNF-α) and CRP levels, serum albumin levels for nutrition assessment, post-operative infectious complications, and length of stay for recovery evaluation. Quality appraisal and meta-analysis were performed using RoB 2.0 and RevMan 5.4, respectively. RESULTS: The result showed that O3FAs significantly reduced IL-6, CRP, and TNF-α, but did not affect IL-1β. Furthermore, the variable slightly increased serum albumin levels and the supplementation led to a decrease in post-operative infectious complications and shortened hospital stays. CONCLUSION: O3FAs as a complementary treatment provided advantages for CRC patients, Further clinical trials and experiments should also be made emphasizing the impact and clinical implementation of O3FA in the nutritional status of CRC patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Digestive Division, Faculty of Medicine, Lambung Mangkurat University, Banjarmasin, Indonesia. Electronic address: agung.wibowo@ulm.ac.id.
- Surgery Resident, Faculty of Medicine, Lambung Mangkurat University, Banjarmasin, Indonesia.
Zitieren
APA
Wibowo, A. A., & Willyanto, N. A. (2024). The efficacy of omega-3 fatty acids (O3FAs) as a complementary in colorectal cancer patients: A systematic review and meta-analysis. Clinical Nutrition ESPEN. https://doi.org/10.1016/j.clnesp.2024.04.002
Vancouver
Wibowo AA, Willyanto NA. The efficacy of omega-3 fatty acids (O3FAs) as a complementary in colorectal cancer patients: A systematic review and meta-analysis. Clinical Nutrition ESPEN. 2024. doi:10.1016/j.clnesp.2024.04.002
BibTeX
@article{Wibowo2024,
author = {Wibowo, Agung Ary and Willyanto, Nathan Aditya},
title = {The efficacy of omega-3 fatty acids (O3FAs) as a complementary in colorectal cancer patients: A systematic review and meta-analysis},
journal = {Clinical Nutrition ESPEN},
year = {2024},
doi = {10.1016/j.clnesp.2024.04.002}
}
EUVIMED